SwanBio Therapeutics

SwanBio Therapeutics

SwanBio Therapeutics

SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
Founded
2017
Raised
$52M
Follow us
Latest funding
$52,000,000
Venture capital (Series A) - 2020
Partners Innovation Fund Syncona Partners LLP
Team Size
1–10
Employees
$52,000,000 Venture capital (Series A)
FinSMEs

SwanBio Therapeutics Raises $52M in Series A